SCHEMBL8056750

SCHEMBL8056750

CC(C)(C)OC(=O)NCC1=CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
KDM4A O75164 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
GFER P55789 1/20 0.38
NAMPT P43490 2/20 0.37
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
TSHR P16473 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRR1 P24046 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30602991 0.78 ALDH1A1 (0.43) LMNAKDM4EKDM4AL3MBTL1GFER
SCHEMBL27340643 0.77 CHRM3 (0.42) CHRM3LMNAKDM4EKDM4AL3MBTL1
SCHEMBL19418223 0.75 TSHR (0.39) LMNAGABRPGABRDGABRA1TSHR
SCHEMBL30602966 0.74 L3MBTL1 (0.39) LMNAKDM4EKDM4AL3MBTL1GFER
SCHEMBL8254705 0.71 KDM4A (0.39) LMNAKDM4EKDM4AL3MBTL1GFER
SCHEMBL572016 0.71 TDP1 (0.46) LMNAKDM4EKDM4AL3MBTL1GFER
SCHEMBL8249310 0.70 KDM4A (0.36) LMNAKDM4EKDM4AL3MBTL1GFER
SCHEMBL8255477 0.70 FPR3 (0.36) LMNAKDM4EKDM4AL3MBTL1GFER
SCHEMBL31450006 0.70 KDM4A (0.42) LMNAKDM4EKDM4AL3MBTL1GFER
SCHEMBL21605488 0.69 ACACB (0.38) KDM4AGFERNAMPTTSHRCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1061076-A1 N-ACYL CYCLIC AMINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-12-20 EP disclosed
US-6140333-A FOR TREATMENT AND/OR PROPHYLAXIS OF DISEASES INCLUDE SUCH RESPIRATORY DISEASES AS CHRONIC OBSTRUCTIVE PULMONARY DISEASES, CHRONIC BRONCHITIS, ASTHMA, CHRONIC RESPIRATORY OBSTRUCTION, PULMONARY FIBROSIS, PULMONARY EMPHYSEMA BANYU PHARMACEUTICAL CO LTD (JP) 2000-10-31 US disclosed